Categories Earnings, Other Industries

Lower alumina demand remains a concern ahead of Alcoa Q1 earnings

Leading producer of Aluminum and bauxite, Alcoa (NYSE:AA), is set to report first-quarter 2019 results on Wednesday, April 17, after the regular trading hours. Analysts expect the Pittsburgh, Pennsylvania-based firm to report a loss of 17 cents per share, as revenues are anticipated to fall 11% year-over-year to $2.76 billion.

The fall in revenues could primarily be attributed to tough macro trends, trade uncertainties and lower demand for alumina. However, thanks to enviable management and diversified global operations, the company might just manage to beat the street estimates.

aluminium
Image by homw from Pixabay

It may be noted that the company has surpassed analysts’ expectations in each of the trailing four quarters.

Over the past few quarters, Alcoa has been working to improve its third-party bauxite sales. Analysts expect revenue from the bauxite unit to be almost flat year-over-year, even as shipments edge up over 1%.

Alumina segment is an area of concern due to a supply glut in the global markets and demand decline in China. Revenue from this segment is expected to decline sharply in the double digits, weighing on the top line.

Alcoa shares have gained 5% since the beginning of this year, underperforming the market. In the trailing 52 weeks, the stock has lost almost half of its value.

 READ: LYFT AND SIX OTHER COMPANIES WENT PUBLIC IN MARCH. FULL LIST

In Q4

In the last reported quarter, Alcoa’s adjusted earnings came in at $0.66 per share surpassing street estimates of $0.62 per share. It’s worth noting that for the same period last year, EPS was $1.04. The decline in earnings was primarily due to a drop in commodity prices which impacted the bottom line.

Revenue for the fourth quarter was $3.34 billion, which was in line with analyst estimates of $3.35 billion and saw an increase of 5% sequentially. The improvement in top line was a result of a spike in metal prices in the first half of 2018 and debt reduction measures taken by the firm.

 

Get access to timely and accurate verbatim transcripts that are published within hours of the event.

Most Popular

Agentforce in focus as Salesforce (CRM) gets ready for Q3 2025 earnings

After delivering mixed results in the first half, Salesforce, Inc. (NYSE: CRM) looks poised to report strong numbers when it publishes third-quarter results next week. The Customer relationship management platform

What to look for when Dollar Tree (DLTR) reports Q3 2024 earnings

Shares of Dollar Tree, Inc. (NASDAQ: DLTR) rose over 5% on Monday. The stock has dropped 27% over the past three months. The discount store chain is scheduled to report

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top